Duane E. DeMong

Statistics

Publications

Citations

H-Index

Active since

1998

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Colorado State University

Johnson & Johnson (United States)

United States Military Academy

Duane E. DeMong is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicinal chemistry, pharmacology, and synthetic medicinal chemistry.

ORCID

Publications per year

1998–2022

Publications

MLi-2, a Potent, Selective, and Centrally Active Compound for Exploring the Therapeutic Potential and Safety of LRRK2 Kinase Inhibition

Matthew Fell, Christian Mirescu, Kallol Basu et al. · Journal of Pharmacology and Experimental Therapeutics · 2015 · 337 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

A Novel Carbohydrate-Glycosphingolipid Interaction between a β-(1–3)-Glucan Immunomodulator, PGG-glucan, and Lactosylceramide of Human Leukocytes

Janet W. Zimmerman, Johanna Lindermuth, Pamela A. Fish et al. · Journal of Biological Chemistry · 1998 · 222 citations · Full text

Life Sciences, Biochemistry, Immunology +16

Discovery of a 3-(4-Pyrimidinyl) Indazole (MLi-2), an Orally Available and Selective Leucine-Rich Repeat Kinase 2 (LRRK2) Inhibitor that Reduces Brain Kinase Activity

Jack D. Scott, Duane E. DeMong, Thomas J. Greshock et al. · Journal of Medicinal Chemistry · 2017 · 148 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +16

Asymmetric Synthesis of (2<i>S</i>,3<i>R</i>)-Capreomycidine and the Total Synthesis of Capreomycin IB

Duane E. DeMong, Robert M. Williams · Journal of the American Chemical Society · 2003 · 72 citations

Pharmacy, Medicinal Chemistry, Drug Design +15

A chemoenzymatic strategy for site-selective functionalization of native peptides and proteins

Anna Fryszkowska, Chihui An, Oscar Alvizo et al. · Science · 2022 · 55 citations

Life Sciences, Biotechnology, Pharmaceutical Biotechnology +16

1–5 of 15